In Vitro Activity of HR 756, a New Cephalosporin, Against Neisseria gonorrhoeae
AUTOR(ES)
Murray, Patrick R.
RESUMO
The in vitro activity of HR 756 was compared with penicillin, cefamandole, cefoxitin, and tetracycline against Neisseria gonorrhoeae. A total of 192 randomly selected isolates (of which 23 had minimal inhibitory concentrations of ≥0.5 μg/ml for penicillin) and three β-lactamase-producing isolates were tested. HR 756 was the most active antibiotic tested, with more than 90% of the isolates inhibited by 0.008 μg/ml and all inhibited by 0.25 μg/ml.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=352682Documentos Relacionados
- In vitro activity of Ro 15-8074, a new oral cephalosporin, against Neisseria gonorrhoeae.
- HR 756, the syn Isomer of a New Methoxyimino Cephalosporin with Unusual Antibacterial Activity
- Beta-Lactamase Stability of HR 756, a Novel Cephalosporin, Compared to That of Cefuroxime and Cefoxitin
- HR 756, a New Cephalosporin Active Against Gram-Positive and Gram-Negative Aerobic and Anaerobic Bacteria
- HR 756, a Highly Active Cephalosporin: Comparison with Cefazolin and Carbenicillin